|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07H 21/04 | |
| A61K 39/395 | |||
| C07K 16/00 | |||
| C12N 15/63 | |||
| G01N 33/53 |
| (11) | Number of the document | 1448584 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02761818.0 |
| Date of filing the European patent application | 2002-09-25 | |
| (97) | Date of publication of the European application | 2004-08-25 |
| (45) | Date of publication and mention of the grant of the patent | 2010-05-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2002/030316 |
| Date | 2002-09-25 |
| (87) | Number | WO 2003/027135 |
| Date | 2003-04-03 |
| (30) | Number | Date | Country code |
| 325360 P | 2001-09-26 | US |
| (72) |
PASTAN, Ira, H., US
SALVATORE, Giuliana, IT
BEERS, Richard, US
KREITMAN, Robert, J., US
|
| (73) |
The Government of the United States of America as represented by The Secretary of Health and Human Services,
Office of Technology Transfer, 6011 Executive Boulevard, Suite No. 325, Rockville, MD 20854,
US
|
| (54) | MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS |
| MUTATED ANTI-CD22 ANTIBODIES WITH INCREASED AFFINITY TO CD22-EXPRESSING LEUKEMIA CELLS |